These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 33130128)

  • 1. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
    Jacobson KA; IJzerman AP; Müller CE
    Biochem Pharmacol; 2021 May; 187():114311. PubMed ID: 33130128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
    Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
    Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonists and Antagonists for Purinergic Receptors.
    Müller CE; Baqi Y; Namasivayam V
    Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonists and antagonists for P2 receptors.
    Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L
    Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors.
    Ryu JK; Kim J; Choi SH; Oh YJ; Lee YB; Kim SU; Jin BK
    Neuroreport; 2002 Sep; 13(13):1611-5. PubMed ID: 12352612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
    Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation.
    Resende RR; Majumder P; Gomes KN; Britto LR; Ulrich H
    Neuroscience; 2007 May; 146(3):1169-81. PubMed ID: 17418494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
    Yu Y; Zhang C
    Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic signaling in kidney disease.
    Menzies RI; Tam FW; Unwin RJ; Bailey MA
    Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.
    Jacobson KA; Kim YC; Wildman SS; Mohanram A; Harden TK; Boyer JL; King BF; Burnstock G
    J Med Chem; 1998 Jun; 41(13):2201-6. PubMed ID: 9632352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine and pyrimidine receptors.
    Burnstock G
    Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New paradigms in purinergic receptor ligand discovery.
    Jacobson KA; Pradhan B; Wen Z; Pramanik A
    Neuropharmacology; 2023 Jun; 230():109503. PubMed ID: 36921890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of natural products on p2 receptors: a reinvented era for drug discovery.
    Faria R; Ferreira L; Bezerra R; Frutuoso V; Alves L
    Molecules; 2012 Nov; 17(11):13009-25. PubMed ID: 23117439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of purinergic signaling in cardiovascular diseases.
    Ralevic V; Burnstock G
    Drug News Perspect; 2003 Apr; 16(3):133-40. PubMed ID: 12819811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purines and pain mechanisms: recent developments.
    Liu XJ; Salter MW
    Curr Opin Investig Drugs; 2005 Jan; 6(1):65-75. PubMed ID: 15675605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cultured dorsal root ganglion neuron P2X receptors.
    Grubb BD; Evans RJ
    Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y receptor-mediated inhibition of voltage-activated Ca(2+) currents in PC12 cells.
    Vartian N; Boehm S
    Eur J Neurosci; 2001 Mar; 13(5):899-908. PubMed ID: 11264662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.